Bicycle Therapeutics BCYC
NASDAQ BCYC
$3.56 -0.12 (-3.26%)
At close: Oct 1, 2026 · 4:00 PM EDT

Bicycle Therapeutics (BCYC) Preferred Stock Liabilities (2018 - 2019)

Updated

Bicycle Therapeutics' Preferred Stock Liabilities came in at $123.78 million for Q1 2019, up 28.3% from $96.44 million a year earlier and up 1.3% from the prior quarter.

Analysis

Bicycle Therapeutics (BCYC) Preferred Stock Liabilities (2018 - 2019) Analysis & Trends

At the end of FY2018, Bicycle Therapeutics' Preferred Stock Liabilities was $122.2 million, up 26.7% from FY2017.

  • Going back by year, Preferred Stock Liabilities was $96.44 million in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Bicycle Therapeutics 256.92 Mn 256.92 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 123.78 Mn
Dec 31, 2018 122.20 Mn
Jun 30, 2018 96.44 Mn
Mar 31, 2018 96.44 Mn
API Access

Bicycle Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=BCYC&period=max&api_key=YOUR_API_KEY